This webinar discussed how to use a PBPK cancer population to investigate tumor disposition and therefore, impact on treatment regimens.
June 27, 2019 –This webinar discussed the Simcyp Animal Simulators, and the role they play in developing safer and more effective medications in the human and veterinary drug development arena.
Advanced Analytics Using RWD Can Mitigate Risks in AD Drug Development, Reimbursement and Utilization
This webinar explained how advanced analytics using real-world data can mitigate challenges in Alzheimer’s disease drug approval, reimbursement and utilization.
This webinar explored a new version of a 21 CFR Part 11 compliant data repository that significantly improves the clinical pharmacology workflow.
This webinar discussed how Certara’s PBPK platform, the Simcyp®️ Simulator, was used to assess the risk-benefit profile for ethinylestradiol, the estrogen component of most combined oral contraceptives.
In this webinar, Leticia Arrington (Merck) and Richard Franzese (Certara) discussed data considerations, analysis methods, and learnings from a recent network MBMA analysis of relevant endpoints in NP that will be used for general competitive landscaping questions to support Merck’s ongoing mission to develop better NP therapies.
This webinar described some important strategic considerations for successful development of complex biologics including appropriate data collection and timings, analyses requiring cross-functional data integration, and key pharmacology-related critical questions.
Modeling and simulation can help veterinarians provide better care for animals and guide research study design thereby maximizing the knowledge gained from research studies whilst minimizing the number of animals used. In this webinar, we looked at how PBPK modeling can be used to predict the absorption, distribution, metabolism, and excretion of drugs in humans and other animal species.
This webinar provided insights that could be used immediately in your development programs and could improve your readiness for deal and investment engagements.
Watch this webinar to learn how to use simulation to anticipate risks and preview the range of possible trial results before millions of R&D dollars are spent exposing subjects to experimental therapies.